In this case, CD45RA+ CD19 CAR-Treg did not present cytolytic activity, although they were able to suppress human B cell Ig production and differentiation into plasma cells in a xenogeneic mouse model of GVHD, also leading to attenuation of the disease. This evidence concerns the gene CD19 and graft versus host disease.